Bayer Wins Hormone-Free Treatment Approval for Women in the UK
The Medicines and Healthcare products Regulatory Agency, a regulatory authority in the UK, has authorized the use of elinzanetant, under the brand name Lynkuet for the above-mentioned indication.
Year to date, shares of Bayer have rallied 67% compared to the industry 's gain of 2.7%.
More on Bayer's Elinzanetant
Elinzanetant is the first dual neurokinin (NK)-targeted therapy (NK-1 and NK- 3 receptor antagonist), which has been globally developed for the treatment of moderate to severe VMS associated with menopause or endocrine therapy for breast cancer, administered orally once daily.
The marketing authorization in the UK marks the drug's first global approval. The approval was based on positive results from the late-stage studies OASIS-1, OASIS-2, and OASIS-3, which evaluated the efficacy and safety profile of elinzanetant. Results from the study showed that elinzanetant met all primary endpoints in all three studies and demonstrated a favorable safety profile.
We note that elinzanetant is under regulatory review in the United States, countries of the European Union and other markets around the world.
The approval of this hormone-free treatment is not only a transformative therapeutic advance for millions of women worldwide but also a compelling growth catalyst for Bayer's pharmaceutical division.
As the first drug targeting both NK-1 and NK-3 receptors, it sidesteps the risks and contraindications associated with estrogen therapy, making it an attractive option for millions, including breast cancer survivors or women avoiding hormone-based interventions.
BAYRY's Efforts to Strengthen Pharma Business
Bayer's new products, such as Nubeqa and Kerendia, continue to maintain their impressive momentum in the Pharmaceutical division and offset the negative impact of a decline in Xarelto sales.
The company is working to expand the labels of these key drugs, which should boost its top-line growth.
Last month, the FDA expanded Nubeqa's label for a third indication for patients with advanced prostate cancer.
The successful development of additional drugs is imperative for Bayer amid multiple challenges. BAYRY expects to launch two new drugs — elinzanetant and acoramidis, a drug for the treatment of a certain type of heart disease.
The company also aims to strengthen its pharmaceutical pipeline. In 2021, Bayer acquired a clinical-stage biopharmaceutical company, Vividion Therapeutics, to expand into precision small-molecule therapeutics, primarily in oncology and immunology.
BAYRY has expanded its pipeline in new modalities of cell therapy through the acquisition of BlueRock, and in gene therapy, through the AskBio buyout.
Bayer's Zacks Rank & Other Key Picks
BAYRY currently carries a Zacks Rank #1 (Strong Buy). A couple of other top-ranked stocks in the large-cap pharma sector are Novartis NVS and Johnson & Johnson JNJ, both carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today's Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Novartis' 2025 earnings per share (EPS) has risen from $8.78 to $8.92 over the past 60 days. EPS estimates for 2026 have jumped 20 cents to $9.27 during the said timeframe. The stock has risen 30.2% so far this year.
J&J's EPS estimate for 2025 has risen from $10.60 to $10.64 over the past 60 days, while that for 2026 has increased from $10.98 to $11.07 over the same timeframe.
#1 Semiconductor Stock to Buy (Not NVDA)
The incredible demand for data is fueling the market's next digital gold rush. As data centers continue to be built and constantly upgraded, the companies that provide the hardware for these behemoths will become the NVIDIAs of tomorrow.
One under-the-radar chipmaker is uniquely positioned to take advantage of the next growth stage of this market. It specializes in semiconductor products that titans like NVIDIA don't build. It's just beginning to enter the spotlight, which is exactly where you want to be.
See This Stock Now for Free >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Novartis AG (NVS): Free Stock Analysis Report
Johnson & Johnson (JNJ): Free Stock Analysis Report
Bayer Aktiengesellschaft (BAYRY): Free Stock Analysis Report
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
National Post
37 minutes ago
- National Post
Derek Burney: Disillusioned Trump tries to talk tough on Ukraine
On first blush following a visit to the White House by NATO Secretary General Mark Rutte, it seemed like Donald Trump had changed his tune on Vladimir Putin. He would typically have a 'lovely conversation' with the Russian leader, the president said, then, soon after, Russian missiles would fly at night against Ukrainian civilians. Article content Trump has agreed to sell much-needed military equipment, like the Patriot air defence missiles and long-range missiles that could reach deep into Russian territory, to European NATO members for transfer to Ukraine. Among other things, the move benefits U.S. defence suppliers. Some European nations intend to send their existing supplies to Ukraine soon and obtain replacements from the U.S. Outstanding questions are: how long it will take to ship the equipment and in what quantity? Article content Article content Trump is intent on extracting the U.S. from the Ukraine conflict, which he often describes as 'Biden's war,' suggesting that Putin would never have invaded Ukraine if Trump had been president. His campaign promise to end the war in 24 hours has fallen to the wayside. He has slow-walked and even paused military shipments to Ukraine authorized by the Biden administration. For six months, Trump has steadfastly ignored the distinction between the aggressor and its victim. At least he has now succeeded in getting Europe to assume more of the burden. But some of the smaller European countries like Hungary are backsliding on NATO commitments to Ukraine. Article content Article content Trump has threatened 100 per cent secondary tariffs on countries that buy Russian oil — namely China, India and Brazil — if there is no progress toward a ceasefire and peace within 50 days — a bit like the tactic he is using unlawfully to extract concessions on trade from friends and foes alike. Trump's sanctions 'threat' is a reprieve enabling Putin to continue his summer offensive that has already subjugated more than 500 square miles of territory in Eastern Ukraine. Putin told Trump in a recent phone call that he intended to push hard for the next 60 days. John Lough of the New Eurasia Strategic Centre's think-tank observed that the intensifying Russian attacks were 'aimed to demoralize Ukraine's population and zap its will to fight.' Article content Article content Meanwhile, 85 members of the U.S. Senate want to vote on a bill that would levy tariffs 'up to 500 per cent' on countries buying Russian oil, but the Republican majority will not move forward without a green light from the White House. Article content Article content The Kremlin has stoutly rejected Trump's 50-day proposition as ' unacceptable. ' Deputy Foreign Minister Sergei Ryabkov told the state-run Tass news agency that Russia's position is 'unshakable.' Article content Despite the excessive flattery expressed by NATO's Secretary General, there are misgivings in Europe about the meaning of Trump's 50-day threat. Kaja Kallas, the EU's foreign policy chief, told reporters in Brussels that, 'Fifty days is a very long time if we see that they are killing innocent civilians every day.' Ukrainian President Volodymyr Zelenskyy, however, diplomatically thanked the U.S. president for 'his willingness to support Ukraine.' Article content No mention was made about the $300+ billion in Russian assets held in the West, primarily in Europe — funds Ukraine could desperately use to repair the infrastructure being demolished by Russian drone and missile attacks.
Globe and Mail
an hour ago
- Globe and Mail
Shipbuilding, aerospace to be priorities in federal strategy to transform defence sector, Joly says
Federal Industry Minister Mélanie Joly says aerospace and shipbuilding are areas where Canada can excel as the government prepares its Defence Industrial Strategy, which aims to transform the country's status as a laggard to a leader in the sector. The strategy, which Ms. Joly said should be finalized in the coming months, will be key in shaping the future of Canada's defence industry, through items such as job creation in manufacturing, strengthened ties with Europe and a renewed relationship with the private sector. 'We're doing this because, fundamentally, we cannot take our peace for granted any more,' she said in an interview Tuesday with The Globe and Mail. Prime Minister Mark Carney has committed to boosting Canada's spending on defence to 2 per cent of its gross domestic product this fiscal year, and to 5 per cent by 2035. The latter NATO target will require Canada spend up to $150-billion annually, more than double its existing budget. How should Canada rearm itself? Fix aging bases, buy submarines, air-defence systems, experts say Through military investment, Ms. Joly said she'd like to see Canada's aerospace sector rebuilt into something that resembles former versions of itself – such as in the 1950s, when the country was known for its Avro Arrow program. She'd also like to see the country's shipyards become an export market for the rest of the world. With the Defence Industrial Strategy on the way, Ms. Joly said the government isn't waiting to take action. Last week, she sent a mandate letter to the Business Development Bank of Canada, a Crown corporation, asking it to work with government on the development of the country's defence sector and sovereign capabilities, such as dual-use technology and military weapons and equipment. More specifically, she asked the bank to support small to medium-sized enterprises that make up the sector's supply chains. In the letter, obtained by The Globe and Mail, Ms. Joly concludes with a request to the BDC to provide her with 'a proposal in alignment with industry best practices to ensure that commercially viable businesses operating in the full scope of defence and security industries can access the financial supports they need to start up, grow and prosper.' It's the first of several mandate letters Ms. Joly will give out to government bodies, such as Export Development Canada, the Canadian Space Agency and the National Research Council, asking them to actively support defence-related businesses and dual-use technologies. First, however, she said the military must be at the table with the private sector to rebuild a level of trust that has been slowly degraded after successive governments failed to adequately invest in defence. 'History has shown us that when you're able to have defence and the private sector really work together, you're able to spear up innovation, make sure that your country is peaceful and, ultimately, create jobs,' Ms. Joly said in the interview. After all, companies want contracts, not subsidies, she said. Supports being rolled out by the government for Canada's steel sector are also part of its push toward building sovereign defence capabilities. For example, Ms. Joly said the country's shipbuilding and aerospace industries should be buying domestic steel. And the fact that these industries have access to a Canadian supply chain for certain materials, such as critical minerals and metals, is a large part of the reason they're being identified as priorities in building strength at home. 'We cannot have a military that is dependent on a manufacturing sector that is either on the other side of the ocean or south of the border.' Opinion: Great defence spending plan, Carney. It'd be a shame if Ottawa bureaucracy got in the way This push to be more self-sustaining is already playing out in actions taken by companies such as Seaspan, which recently signed a memorandum of understanding with Ontario-based Algoma Steel Inc. ASTL-T and Stigterstaal Canada. The partnership was formed specifically to assess the feasibility of Algoma supplying steel to Seaspan to contribute to the future of Canada's shipbuilding sector. Strategic partnerships beyond our own borders will also be a key part of the Defence Industrial Strategy. While the U.S. continues to make decisions around tariffs and its economy that serve itself, Ms. Joly said Canada is working with other countries and NATO members to become more connected. 'The test of this is actually the Defence Industrial Strategy because we will need to be working more with Europe on this, and obviously NATO, while continuing to understand that a lot of our companies are American-owned,' she said, referring to the fact that roughly 40 per cent of the 600 companies that make up Canada's industrial base are subsidiaries of U.S.-headquartered firms. Canada is open to foreign direct investment, she said, but not at the sacrifice of its own sovereign capabilities: 'We won't be an economy of subsidiaries. We will own IP and we will be able to lead the world.' Defence is a priority for this Liberal government because the world is a more dangerous place, Ms. Joly said, and Canada needs a military it can rely upon to defend itself.
Globe and Mail
3 hours ago
- Globe and Mail
Dentsu Expands Partnership with Magnite to Streamline CTV and Video Activation Across EMEA
LONDON, July 23, 2025 (GLOBE NEWSWIRE) -- Magnite (NASDAQ: MGNI), the largest independent sell-side advertising company, has announced a strategic partnership with dentsu in EMEA to accelerate innovation and performance across the media supply chain. Dentsu is tapping into Magnite's built-for-video tools and technology to power dentsu Total TV and support its ambition to lead in the 'Algorithmic Era' of advertising, where interoperability, automation and outcome-driven planning are key. Across multiple EMEA markets, including Spain and the UK, the Magnite SpringServe video platform is empowering dentsu with more efficient, data-rich connections to inventory, enabling them to curate premium media experiences with greater precision, transparency and scale. From video and CTV to emerging formats, the partnership reflects a shared commitment to evolving how media is deployed and optimised, with client performance at the centre. 'Our relationship with dentsu is a great example of how technology and collaboration can unlock real value,' said Julie Selman, SVP, Head of EMEA at Magnite. 'We're proud to support dentsu's vision for the future by providing the tools and insights needed to deliver stronger results and a more efficient media experience for clients and publishers alike.' 'In this new era of advertising, media must work harder, smarter and faster,' said Ben Angove, President, Amplifi EMEA & Chief Strategy Officer, Amplifi Global at dentsu. 'At dentsu, we are committed to building Next Gen media solutions in partnership with best-in-class technologies that ultimately enable our clients to win and grow in the Algorithmic Era. Our partnership with Magnite gives us the tools to do just that - connecting the right data with the right inventory to drive better results for our clients across the region.' Magnite's technology plays a key role in helping dentsu move beyond transactional media buying, towards a more curated, high-performance approach. The collaboration helps dentsu gain greater visibility and control of their media buys, enabling more intelligent decision-making and unlocking new opportunities for optimisation across the media ecosystem. Press contact Paige Brewer, Account Executive, Bluestripe Group magnite@ About Magnite We're Magnite (NASDAQ: MGNI), the world's largest independent sell-side advertising company. Publishers use our technology to monetize their content across all screens and formats including CTV, online video, display, and audio. The world's leading agencies and brands trust our platform to access brand-safe, high-quality ad inventory and execute billions of advertising transactions each month. Anchored in bustling New York City, sunny Los Angeles, mile high Denver, historic London, colorful Singapore, and down under in Sydney, Magnite has offices across North America, EMEA, LATAM, and APAC.
